InsidersTradesSigma
Browse the detailed record of transactions filed by ARONSTAM PETER, Chief Financial Officer. Director active across 1 companies, notably Cytocom, Inc.. Aggregated, 2 disclosures have been recorded. The latest transaction was disclosed on 27 July 2021 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
ARONSTAM PETER is Chief Financial Officer at Cytocom, Inc. In this role, he is responsible for financial management and budgeting strategy for the company. His expertise in finance allows him to optimize financial performance and ensure regulatory compliance. Peter plays a key role in strategic planning and financial results analysis.